Why the study?
Does heart transplantation provide comparable survival in patients with hypertrophic cardiomyopathy compared to those with non-HCM cardiovascular diseases?
Does heart transplantation provide comparable survival in patients with hypertrophic cardiomyopathy compared to those with non-HCM cardiovascular diseases?
Survival after heart transplantation for hypertrophic cardiomyopathy is comparable to or potentially better than survival for other cardiovascular diseases.
Supports transplant evaluation in advanced HCM; leaves open prospective confirmation of survival trends.
HCM patients compose a small subset (1%) of the overall population of patients who undergo heart transplantation in the United States. Nonetheless, survival after transplant among HCM patients is comparable to that of patients transplanted for non-HCM cardiovascular diseases, with possible enhanced survival over time.
No takes yet. Share an insight, caveat, or question.
Maron et al. (2010) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: